Document is current
Any future updates will be listed below
-
Authors
Ge, Long
Wang, Qi
He, Yihan
Wu, Darong
Zhou, Qi
Xu, Nenggui
Yang, Kehu
Chen, Yaolong
Zhang, Anthony Lin
Hua, Haiqing
Huang, Jinchang
Hui, Ka-Kit
Liang, Fanrong
Wang, Linpeng
Xu, Bin
Yang, Yufei
Zhang, Weimin
Zhao, Baixiao
Zhu, Bing
Guo, Xinfeng
Xue, Charlie Changli
Zhang, Haibo
,
Xue, Charlie Changli
Zhang, Haibo
Guo, Xinfeng
Wu, Darong
Yang, Kehu
Chen, Yaolong
Ge, Long
He, Runsen
Hua, Haiqing
Huang, Jinchang
Hui, Ka-Kit
Liang, Fanrong
Pan, Zuodi
Wang, Linpeng
Xu, Bin
Xu, Nenggui
Yang, Yufei
Zhang, Anthony Lin
Zhang, Weimin
Zhao, Baixiao
Zhu, Bing
Wang, Qi
He, Yihan
Zhou, Qi
Yang, Lihong
Liu, Shaonan
Li, Jieyun
Hou, Liangying
Zhang, Qian
Lai, Honghao
Chen, Xueling
Deng, Xueyi
Kang, Fuqin
-
Funding
Funding for this research was provided by:
National Key R&D Program, China National Centre for Biotechnology Development (No.2019YFC1709805)
- License Information
-
More Information
Article History
Received: 29 October 2021
Accepted: 15 December 2021
First Online: 5 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: The guideline development was initiated by the international Trustworthy traditional Chinese Medicine Recommendations (TCM Recs) Working Group. Guangdong Provincial Hospital of Chinese Medicine and Evidence-Based Medicine Centre of Lanzhou University led the guideline development following the universal methodology by reaching the final consensus based on the latest research evidence and multidisciplinary expert opinions. All guideline panel members have completed the TCM Recs interest disclosure form. The TCM Recs judged that no panel member had any financial conflict of interest. Professional and academic interests are minimized as much as possible. Besides, we declare that the guideline will not be disseminated for commercial promotions.
